Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 180 shares, an increase of 386.5% from the July 15th total of 37 shares. Based on an average daily trading volume, of 2,823 shares, the days-to-cover ratio is presently 0.1 days.
Carl Zeiss Meditec Stock Up 1.9%
Shares of Carl Zeiss Meditec stock traded up $0.65 during trading on Thursday, hitting $35.06. 109 shares of the stock were exchanged, compared to its average volume of 4,441. The company has a fifty day moving average price of $32.16 and a 200-day moving average price of $31.08. Carl Zeiss Meditec has a 1-year low of $26.65 and a 1-year high of $55.94.
Analysts Set New Price Targets
CZMWY has been the subject of a number of recent research reports. Zacks Research downgraded Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Tuesday. UBS Group downgraded shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce”.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
